SFDA bans cosmetic products packaged as syringes, ampoules, and vials
RIYADH — The Saudi Food and Drug Authority (SFDA) has decided to ban the circulation of cosmetic products intended for external use that are packaged in forms resembling pharmaceutical products, such as ampoules, vials, and syringes, effective from January 1, 2027. In a recent circular addressed to cosmetic product manufacturers and importers, the SFDA stated that it had observed the circulation…
The Saudi Food and Drug Authority (SFDA) has announced a ban on cosmetic products packaged in a manner that resembles pharmaceutical products, including ampoules, vials, and syringes. This decision, effective from January 1, 2027, was made in a circular to manufacturers and importers of cosmetic products.
The SFDA emphasized the importance of adhering to specific conditions for the circulation of these products. Firstly, the sale of cosmetic products in syringe form is strictly prohibited. Secondly, certain instructions must be clearly printed in both Arabic and English on the packaging of ampoule and vial products. These include:
1. The product is for external use only.
2. It is not for injection.
3. Avoid contact with eyes.
4. It must be opened with caution.
Moreover, any advertising, promotion, or marketing of these products must not imply their use by injection or through any device that penetrates the skin. Establishments have been granted until December 31, 2026, to recall such products from the market and ensure compliance with regulatory standards.
Failure to comply with these provisions will result in legal action against both the products and the establishments involved after the deadline set in the fourth point.
Written by urgent.news from Saudi Gazette's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
